OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
51
Results
Show all
Save search
Copy query
Show results for
Unknown
(38)
Genomics
(13)
Organisms
Homo sapiens
(13)
Repository
EGA
(13)
Technology Type
Illumina 15K
(8)
Publication Date
Release Date
2025
(8)
2022
(6)
2024
(4)
2023
(4)
2021
(4)
2018
(3)
2015
(3)
2020
(2)
2017
(2)
2014
(1)
2013
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk.
Not available
S-EPMC5972004
|
biostudies-literature
Cite
Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney.
Not available
S-EPMC5783787
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Dexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595
|
biostudies-literature
Cite
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Not available
S-EPMC7556338
|
biostudies-literature
Cite
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998
|
biostudies-literature
Cite
ATD
WTCCC1 project Autoimmune Thyroid Disease (ATD) samples
EGAD00000000011
|
EGA
Cite
BC
WTCCC1 project Breast cancer (BC) samples
EGAD00000000013
|
EGA
Cite
MS
WTCCC1 project Multiple Sclerosis (MS) samples
EGAD00000000012
|
EGA
Cite
WTCCC2 Ankylosing spondylitis cases - individual
WTCCC1 project Ankylosing Spondylitis (AS) samples
EGAD00000000010
|
EGA
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets